BIOLASE Announces Pricing of $8.5 Million Public Offering of Common Stock and Concurrent Private Placement of Convertible Preferred Stock

IRVINE, Calif., Oct. 24, 2019 /PRNewswire/ -- BIOLASE, Inc. (Nasdaq: BIOL), the global leader in dental lasers, today announced the pricing of an underwritten public offering of 7,820,000 shares of its common stock at a price to the public of $0.5750 per share. In addition, BIOLASE has...

from PR Newswire: https://ift.tt/2PjcCDC